Physician profile
Derek Moss
NPI 1023078193
$2,472.99
in general payments reported to CMS, 2019-2025
16 companies · $248 in 2025
The $248 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $79.83 · 2021: $465 · 2022: $443 · 2023: $326 · 2024: $625 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $841.94 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $347.05 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $269.43 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $247.85 | 2019-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $175.49 | 2019-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Pfizer INC. | $143.79 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $90.71 | 2019-2022 | |
| Sanofi Pasteur INC. | $81.46 | 2020-2025 | |
| Collegium Pharmaceutical, INC. | $73.80 | 2025 | Jornay Pm |
| Genentech USA, INC. | $58.66 | 2019-2021 | |
| Glaxosmithkline, LLC. | $39.79 | 2019-2021 | |
| Sobi, INC | $28.65 | 2019-2022 | |
| Adlon Therapeutics L.P. | $22.96 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $21.91 | 2024 | |
| Arbor Pharmaceuticals, INC. | $15.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.